Search results
AbbVie's Humira gets a U.S. rival, but costs could stay high
Reuters via Yahoo Finance· 1 year agoU.S. patients will finally get access to cheaper versions of AbbVie Inc’s blockbuster arthritis drug...
This Blockbuster Drug's Latest News Could Be Another Home Run for AbbVie
Motley Fool· 1 year agoAbbVie (NYSE: ABBV) recently shared positive top-line results from its phase 3 clinical trial of...
What Could This Drug News Mean for AbbVie?
Motley Fool· 2 years agoIn late July, AbbVie (NYSE: ABBV) applied for a new indication with the European Medicines Agency (EMA) for Rinvoq to treat adult patients with...
Cheaper competition for Humira is hitting the market, but savings will depend on your insurance
AP Finance via Yahoo Finance· 12 months agoPatients who take the autoimmune disease treatment Humira may see some price relief when several...
This Blockbuster Drug from AbbVie Is Closer to Another Major Indication
Motley Fool· 2 years agoThe European Medicine Agency's Committee for Medicinal Products for Human Use (CHMP) recently...
Humira: the highs and lows of the world’s best-selling drug
Pharmaceutical Technology via Yahoo Finance· 4 days agoHumira, an arthritis medication with indications for colitis and psoriasis is the world’s...
Why Investors Should Care About Novartis' Latest Label Expansion -- It Could Mean Billions
Motley Fool· 1 year agoEarlier this month, Novartis' (NYSE: NVS) smash-hit immunology medicine Cosentyx became the first...
Could This Indication Provide a Lift for Bristol Myers Squibb's Stock?
Motley Fool· 1 year agoLate last month, Bristol Myers Squibb's (NYSE: BMY) immunology drug, Sotyktu, received good news....
Cancer Is Capsizing Americans’ Finances. ‘I Was Losing Everything.’
The Wall Street Journal· 4 weeks agoHEALTH NEWS Gwendolyn Jackson was financially sound before her cervical cancer diagnosis—she was...
Good news for consumers, bad news for AbbVie as its blockbuster drug Humira faces competition
Chicago Tribune via Yahoo News· 1 year agoCHICAGO — One of the most popular prescription medications in the world is about to face fierce competition in the U.S. — something that could mean lower prices for the drug but a difficult ...